The discovery of tetrahydro-beta-carbolines as inhibitors of the kinesin Eg5.
Barsanti, P.A., Wang, W., Ni, Z.J., Duhl, D., Brammeier, N., Martin, E., Bussiere, D., Walter, A.O.(2010) Bioorg Med Chem Lett 20: 157-160
- PubMed: 19945875 
- DOI: https://doi.org/10.1016/j.bmcl.2009.11.012
- Primary Citation of Related Structures:  
3K3B - PubMed Abstract: 
A series of tetrahydro-beta-carbolines were identified by HTS as inhibitors of the kinesin Eg5. Molecular modeling and medicinal chemistry techniques were employed to explore the SAR for this series with a focus of removing potential metabolic liabilities and improving cellular potency.
Organizational Affiliation: 
Global Discovery Chemistry/Oncology and Exploratory Chemistry, Novartis Institutes for Biomedical Research, 5400 Hollis Street, Emeryville, CA 94608, USA. paul.barsanti@novartis.com